A Novel Porcine Model of Ventilator-associated Pneumonia Caused by Oropharyngeal Challenge with Pseudomonas aeruginosa

2014 ◽  
Vol 120 (5) ◽  
pp. 1205-1215 ◽  
Author(s):  
Gianluigi Li Bassi ◽  
Montserrat Rigol ◽  
Joan-Daniel Marti ◽  
Lina Saucedo ◽  
Otavio T. Ranzani ◽  
...  

Abstract Background: Animal models of ventilator-associated pneumonia (VAP) in primates, sheep, and pigs differ in the underlying pulmonary injury, etiology, bacterial inoculation methods, and time to onset. The most common ovine and porcine models do not reproduce the primary pathogenic mechanism of the disease, through the aspiration of oropharyngeal pathogens, or the most prevalent human etiology. Herein the authors characterize a novel porcine model of VAP due to aspiration of oropharyngeal secretions colonized by Pseudomonas aeruginosa. Methods: Ten healthy pigs were intubated, positioned in anti-Trendelenburg, and mechanically ventilated for 72 h. Three animals did not receive bacterial challenge, whereas in seven animals, a P. aeruginosa suspension was instilled into the oropharynx. Tracheal aspirates were cultured and respiratory mechanics were recorded. On autopsy, lobar samples were obtained to corroborate VAP through microbiological and histological studies. Results: In animals not challenged, diverse bacterial colonization of the airways was found and monolobar VAP rarely developed. In animals with P. aeruginosa challenge, colonization of tracheal secretion increased up to 6.39 ± 0.34 log colony-forming unit (cfu)/ml (P < 0.001). VAP was confirmed in six of seven pigs, in 78% of the cases developed in the dependent lung segments (right medium and lower lobes, P = 0.032). The static respiratory system elastance worsened to 41.5 ± 5.8 cm H2O/l (P = 0.001). Conclusions: The authors devised a VAP model caused by aspiration of oropharyngeal P. aeruginosa, a frequent causative pathogen of human VAP. The model also overcomes the practical and legislative limitations associated with the use of primates. The authors’ model could be employed to study pathophysiologic mechanisms, as well as novel diagnostic/preventive strategies.

2020 ◽  
pp. 106002802098302
Author(s):  
Ting Ji ◽  
Xingxing Zhu ◽  
Futai Shang ◽  
Xiangcheng Zhang

Background: Researchers had contradictory conclusions about the role of probiotics in preventing ventilator-associated pneumonia (VAP), which has led to the controversial use of probiotics in mechanically ventilated patients. Objective: To explore the efficacy and safety of probiotics in preventing VAP. Methods: A literature search was conducted in 7 medical databases. Two investigators assessed literature quality independently and collected data. The primary outcome was the incidence of VAP. Secondary outcomes included 16 measures. Sensitivity analysis and subgroup and meta-regression analyses were performed to analyze the source of heterogeneity. P values <0.05 were considered statistically significant, and CIs were set at 95%. A random-effects model was set when I2 <50%, otherwise a fixed-effects model was used. Results: A total of 20 randomized controlled studies with a total of 2428 patients were analyzed. Pooled results showed positive effects of probiotics on the reduction of VAP incidence (risk ratio [RR] = 0.672; P < 0.001; I2 = 11.3%), length of ICU stay (WMD = −1.417; P = 0.012; I2 = 90.7%), oropharyngeal (RR = 0.866; P = 0.031; I2 = 12.4%) and gastric (RR = 0.645; P < 0.001; I2 = 30.2%) colonization. Conclusions and Relevance: Probiotics can reduce the incidence of VAP and reduce oropharyngeal and gastric bacterial colonization. The results also suggest that probiotics do not cause adverse effects.


2021 ◽  
Vol 3 (2) ◽  
pp. 109-114
Author(s):  
Asma Elkammoshi ◽  
◽  
Abir Ben Ashur ◽  
Hamida El Magrahi ◽  
Aya Abdulatif ◽  
...  

Introduction: In mechanically ventilated patients, ventilator-associated pneumonia (VAP) is a major cause of prolonged hospitalization with increased morbidity and mortality. There is a lack of studies on the relationship between bacterial colonization of the ventilator circuit (VC) and VAP. This study aimed to investigate the role of bacterial colonization of VC in the development of VAP and identify antibiotic susceptibility trends for isolated strains. Methods: A prospective study of the bacterial culture has been performed between February 2021 to March 2021 on a total of 100 mechanically ventilated patients, (n =50) samples have been obtained from patient's lower respiratory tract (LRT) and (n =50) were taken from mechanical ventilator equipment VC. Paired samples of bacteria isolated from VC and LRT, where VC was colonized before LRT. Results: A total of 58 samples were cultured positively, while 42 specimens showed negative bacterial growth. However, there was no substantial difference in comparing between the bacterial colonization of the ventilator system and the patient samples. Most isolated organisms were gram-negative bacteria which were found in the ventilator circuit with 26 (68.4%), and 14 (70%) in patient’s LRT. Gram-positive was detected in 12 (31.6%) and 6 (30%) of the ventilator circuit, and patient's LRT, respectively. The predominant bacterial type was Acinetobacter baumannii organism at the VC with 10 (26.3%) and LRT at 4 (20%) followed by Klebsiella pneumoniae (8 (21.1%) in VC and 4 (20%) in LRT). Moreover, A. baumannii showed a full resistance to amoxicillin and the first generation of cephalosporins, while the other bacterial types were resistant to the most antibiotics used in this research. Conclusions: Bacterial colonization of ventilator circuit VC is a significant cause of VAP development in mechanically ventilated patients. Preventive strategies for the early detection and decontamination of contaminated VC can play a crucial role in ventilator-associated pneumonia prevention.


Author(s):  
Chirag Patel ◽  
M B Shah ◽  
Chirag Modi ◽  
Ankit Thakor

Background:  In critical care units, Ventilator-associated pneumonia (VAP) is a common device-associated infection in mechanically ventilated patients. Problem gets worst of associated with biofilm producing organism with higher antimicrobial resistance. The current study was carried out to observe the pattern of antimicrobial resistance, biofilm forming capacity of isolates causing Ventilator-associated pneumonia and other risk factors associated with VAP patients in intensive care units of Shree Krishna Hospital, Karamsad. Methodology:  97 total tracheal aspirate culture isolates recovered from 83 mechanically ventilated patients diagnosed to be suffering from VAP as per NHSN definition, admitted in various ICUs of Shree Krishna Hospital, Karamsad during the study duration were included in the study. Relevant clinical history of the patients and other details taken for various patient variable factors like age, gender, co-morbid conditions, indoor days, ventilator days, final patient outcome and other lab based investigations done as indicator of active pneumonia or sepsis from the electronic hospital database available on hospital information system. The tracheal aspirate culture isolates were then tested for antimicrobial susceptibility testing by Vitek2compact and in-vitro biofilm production assay using microtitre plate method. Objective of the present study was to determine the incidence of antimicrobial resistance, biofilm forming capacity of VAP pathogens, to determine risk factors associated and final outcome in VAP patients infected with biofilm forming pathogens. Chi-square test was used to check the relation between the categorical variables while t test was applied in case of continuous variables. A p value less than 0.05 was considered as statistically significant. Results:  Out of total 83 patients of VAP, 97 isolates recovered in tracheal aspirate culture. Out of total 83 patients, 42 patients (49 isolates) were found Biofilm producer (BFP) and 41 patients (48 isolates) were found Biofilm non-producer (BFNP). Out of 97 culture total isolates, the most common organisms grew were Klebsiella pneumoniae (29 isolates), Acinetobacter baumani (28 isolates) and Pseudomonas aeruginosa (19 isolates) apart from them lesser number of isolates of Staphylococcus aureus (6), Escherichia coli (5), Pantoea spp. (2), Serretia marcescens (2), Pseudomonas putida (1), Sphingomonas paucimobilis (1), Stenotrophomonas maltophila (1), Enterococcus faecium (1), Candida famata (1) and Candida tropicalis (1). The antimicrobial resistance was compared in three major pathogen between BFP and BFNP isolates, i.e. Klebsiella pneumoniae, Acinetobacter baumani and Pseudomonas aeruginosa, which was found to be statistically insignificant. Mortality was recorded higher in BFP patients (16.67%) compared to BFNP patients (7.3%) of VAP, but statistically it was not found to be significant (p value > 0.05). Conclusions:  Incidence of BFP and BFNP associated VAP seen 50.51% and 49.49% respectively out of total 97 isolates. Biofilm forming pathogen causing VAP may not influence the outcome of the patient but, biofilm producer pathogens continue to be associated with pathogens causing VAP in significant amount of total cases. Typical hospital acquired strains like Klebsiella pneumoniae, Acinetobacter baumani and Pseudomonas aeruginosa is recorded frequently compared to other pathogens. Key words: Intensive Care Unit, anti-microbial resistance, VAP, Bio film, Health care associated infection, Indwelling device associated infection.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Nermeen A. Abdelaleem ◽  
Hoda A. Makhlouf ◽  
Eman M. Nagiub ◽  
Hassan A. Bayoumi

Abstract Background Ventilator-associated pneumonia (VAP) is the most common nosocomial infection. Red cell distribution width (RDW) and neutrophil-lymphocyte ratio (NLR) are prognostic factors to mortality in different diseases. The aim of this study is to evaluate prognostic efficiency RDW, NLR, and the Sequential Organ Failure Assessment (SOFA) score for mortality prediction in respiratory patients with VAP. Results One hundred thirty-six patients mechanically ventilated and developed VAP were included. Clinical characteristics and SOFA score on the day of admission and at diagnosis of VAP, RDW, and NLR were assessed and correlated to mortality. The average age of patients was 58.80 ± 10.53. These variables had a good diagnostic performance for mortality prediction AUC 0.811 for SOFA at diagnosis of VAP, 0.777 for RDW, 0.728 for NLR, and 0.840 for combined of NLR and RDW. The combination of the three parameters demonstrated excellent diagnostic performance (AUC 0.889). A positive correlation was found between SOFA at diagnosis of VAP and RDW (r = 0.446, P < 0.000) and with NLR (r = 0.220, P < 0.010). Conclusions NLR and RDW are non-specific inflammatory markers that could be calculated quickly and easily via routine hemogram examination. These markers have comparable prognostic accuracy to severity scores. Consequently, RDW and NLR are simple, yet promising markers for ICU physicians in monitoring the clinical course, assessment of organ dysfunction, and predicting mortality in mechanically ventilated patients. Therefore, this study recommends the use of blood biomarkers with the one of the simplest ICU score (SOFA score) in the rapid diagnosis of critical patients as a daily works in ICU.


2021 ◽  
Vol 11 (3) ◽  
pp. 164
Author(s):  
Mahmoud Al-Obeidallah ◽  
Dagmar Jarkovská ◽  
Lenka Valešová ◽  
Jan Horák ◽  
Jan Jedlička ◽  
...  

Porcine model of peritonitis-induced sepsis is a well-established clinically relevant model of human disease. Interindividual variability of the response often complicates the interpretation of findings. To better understand the biological basis of the disease variability, the progression of the disease was compared between animals with sepsis and septic shock. Peritonitis was induced by inoculation of autologous feces in fifteen anesthetized, mechanically ventilated and surgically instrumented pigs and continued for 24 h. Cardiovascular and biochemical parameters were collected at baseline (just before peritonitis induction), 12 h, 18 h and 24 h (end of the experiment) after induction of peritonitis. Analysis of multiple parameters revealed the earliest significant differences between sepsis and septic shock groups in the sequential organ failure assessment (SOFA) score, systemic vascular resistance, partial pressure of oxygen in mixed venous blood and body temperature. Other significant functional differences developed later in the course of the disease. The data indicate that SOFA score, hemodynamical parameters and body temperature discriminate early between sepsis and septic shock in a clinically relevant porcine model. Early pronounced alterations of these parameters may herald a progression of the disease toward irreversible septic shock.


Antibiotics ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 78
Author(s):  
Viviane C. Oliveira ◽  
Ana P. Macedo ◽  
Luís D. R. Melo ◽  
Sílvio B. Santos ◽  
Paula R. S. Hermann ◽  
...  

Although different strategies to control biofilm formation on endotracheal tubes have been proposed, there are scarce scientific data on applying phages for both removing and preventing Pseudomonas aeruginosa biofilms on the device surface. Here, the anti-biofilm capacity of five bacteriophages was evaluated by a high content screening assay. We observed that biofilms were significantly reduced after phage treatment, especially in multidrug-resistant strains. Considering the anti-biofilm screens, two phages were selected as cocktail components, and the cocktail’s ability to prevent colonization of the endotracheal tube surface was tested in a dynamic biofilm model. Phage-coated tubes were challenged with different P. aeruginosa strains. The biofilm growth was monitored from 24 to 168 h by colony forming unit counting, metabolic activity assessment, and biofilm morphology observation. The phage cocktail promoted differences of bacterial colonization; nonetheless, the action was strain dependent. Phage cocktail coating did not promote substantial changes in metabolic activity. Scanning electron microscopy revealed a higher concentration of biofilm cells in control, while tower-like structures could be observed on phage cocktail-coated tubes. These results demonstrate that with the development of new coating strategies, phage therapy has potential in controlling the endotracheal tube-associated biofilm.


Sign in / Sign up

Export Citation Format

Share Document